双刃剑:某三级医疗中心体外膜氧合治疗COVID-19相关重度急性呼吸窘迫综合征的神经系统并发症与死亡率
本临床病例系列报告12例COVID-19相关重度急性呼吸窘迫综合征患者接受体外膜氧合治疗期间的神经系统并发症经验,发现颅内出血率达41.7%,高于既往数十年体外膜氧合治疗所有病因急性呼吸窘迫综合征的Meta分析数据及近期COVID-19患者神经系统并发症基线数据,作者提出体外膜氧合相关血液学改变与COVID-19炎症及凝血病改变的交互作用可能为原因,并认为需继续分析。
要点
- 12例COVID-19相关重度急性呼吸窘迫综合征接受体外膜氧合治疗的患者中,颅内出血率为41.7%。
- 神经影像显示的并发症率高于既往体外膜氧合治疗所有急性呼吸窘迫综合征病因的Meta分析数据。
- 神经影像显示的并发症率亦高于近期描述所有COVID-19患者神经系统并发症发生率的基线数据。
核心结论
- 本病例系列发现体外膜氧合治疗COVID-19相关重度急性呼吸窘迫综合征患者神经影像所示并发症率高于既往Meta分析数据及COVID-19基线数据,颅内出血率为41.7%。
- 作者假设体外膜氧合固有的血液学改变与COVID-19病程中炎症及凝血病改变的交互作用导致了上述并发症。
- 作者认为需继续分析该疾病范式下的体外膜氧合治疗。
研究设计与样本
- 临床病例系列,纳入12例接受体外膜氧合治疗的COVID-19相关重度急性呼吸窘迫综合征患者,来自某三级医疗中心。
- 以神经影像显示神经系统并发症,并与既往数十年体外膜氧合治疗所有急性呼吸窘迫综合征病因的Meta分析数据及近期所有COVID-19患者神经系统并发症发生率的基线数据进行比较。
- 展示了代表性病例及毁灭性颅内出血的影像。
关键影像表现/征象
- 12例患者队列中颅内出血率为41.7%。
- 展示了代表性病例及毁灭性颅内出血的影像。
诊断标准与关键数值
- 12例患者队列中颅内出血率为41.7%。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文报告为临床病例系列,样本为12例患者队列。
- 作者认为需继续分析该疾病范式下的体外膜氧合治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In this clinical case series, we report our experience to date with neurologic complications of extracorporeal membrane oxygenation therapy for COVID-19 Acute Respiratory Distress Syndrome. We have found an unexpectedly increased rate of complications as demonstrated by neuroimaging compared with meta-analysis data in extracorporeal membrane oxygenation therapy for all Acute Respiratory Distress Syndrome etiologies over the past few decades and compared with the most recent baseline data describing the incidence of neurologic complication in all patients with COVID-19. For our 12-patient cohort, there was a rate of intracranial hemorrhage of 41.7%. Representative cases and images of devastating intracranial hemorrhage are presented. We hypothesize that the interplay between hematologic changes inherent to extracorporeal membrane oxygenation and inflammatory and coagulopathic changes that have begun to be elucidated as part of the COVID-19 disease process are responsible. Continued analysis of extracorporeal membrane oxygenation therapy in this disease paradigm is warranted.
引用
- Masur J, Freeman CW, Mohan S, et al. A Double-Edged Sword: Neurologic Complications and Mortality in Extracorporeal Membrane Oxygenation Therapy for COVID-19-Related Severe Acute Respiratory Distress Syndrome at a Tertiary Care Center. AJNR Am J Neuroradiol. 2020. PMID: 32855187. doi:10.3174/ajnr.A6728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。